ASTRO APEx

Authors

Nicholas G Zaorsky
Anthony G Ricco
Thomas M Churilla
Eric M Horwitz
Robert B Den

Publication/Presentation Date

11-1-2016

Abstract

AIM: To analyze malpractice trials in radiation oncology and assess how ASTRO APEx

METHODS: The Westlaw database was reviewed using PICOS/PRISMA methods. Fisher's exact and Mann-Whitney U tests were used to find factors associated with outcomes.

RESULTS: Of 34 cases identified, external beam was used in 26 (77%). The most common factors behind malpractice were excessive toxicity (80%) and lack of informed consent (66%). ASTRO APEx pillars and ROI-LS had applicability to all but one case. Factors favoring the defendant included statute of limitations (odds ratio: 8.1; 95% CI: 1.3-50); those favoring the plaintiff included patient death (odds ratio: 0.7; 95% CI: 0.54-0.94).

CONCLUSION: APEx and RO-ILS are applicable to malpractice trials in radiation oncology.

Volume

12

Issue

22

First Page

2643

Last Page

2657

ISSN

1744-8301

Published In/Presented At

Zaorsky, N. G., Ricco, A. G., Churilla, T. M., Horwitz, E. M., & Den, R. B. (2016). ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology. Future oncology (London, England), 12(22), 2643–2657. https://doi.org/10.2217/fon-2016-0131

Disciplines

Medicine and Health Sciences | Oncology

PubMedID

27470145

Department(s)

Department of Radiation Oncology

Document Type

Article